Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eleven Biotherapeutics, Inc. | 65,000 | reported | 22 Jun 2022 | tx 5+374,500 |
| TREVENA INC | 25,234 | reported | 08 Oct 2024 | tx 38+5,518,450−473,206 |
| Nabriva Therapeutics AG | 9,933 | reported | 01 Aug 2022 | tx 10+199,300−9,317 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Oct 2024 | TAX_WITHHOLDING | TREVENA INC | 1,055 | 1.47 USD | |
| 08 Oct 2024 | TAX_WITHHOLDING | TREVENA INC | 54 | 1.47 USD | |
| 08 Oct 2024 | TAX_WITHHOLDING | TREVENA INC | 143 | 1.47 USD | |
| 08 Oct 2024 | TAX_WITHHOLDING | TREVENA INC | 285 | 1.47 USD | |
| 08 Oct 2024 | TAX_WITHHOLDING | TREVENA INC | 285 | 1.47 USD | |
| 14 Dec 2023 | GRANT_AWARD | TREVENA INC | 100,000 | 0.61 USD | |
| 14 Dec 2023 | TAX_WITHHOLDING | TREVENA INC | 7,123 | 0.61 USD | |
| 14 Dec 2023 | GRANT_AWARD | TREVENA INC | 370,000 | 0.61 USD | |
| 02 Dec 2023 | TAX_WITHHOLDING | TREVENA INC | 1,343 | 0.59 USD | |
| 02 Dec 2023 | TAX_WITHHOLDING | TREVENA INC | 3,562 | 0.59 USD | |
| 02 Dec 2023 | TAX_WITHHOLDING | TREVENA INC | 7,123 | 0.59 USD | |
| 06 Jan 2023 | GRANT_AWARD | TREVENA INC | 100,000 | 0.00 USD | |
| 17 Dec 2022 | TAX_WITHHOLDING | TREVENA INC | 1,342 | 1.55 USD | |
| 02 Dec 2022 | TAX_WITHHOLDING | TREVENA INC | 3,560 | 3.42 USD | |
| 01 Aug 2022 | SALE | Nabriva Therapeutics AG | 8,540 | 0.17 USD | |
| 22 Jun 2022 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 40,000 | 0.00 USD | |
| 22 Jun 2022 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 17 Dec 2021 | TAX_WITHHOLDING | TREVENA INC | 33,546 | 0.70 USD | |
| 06 Dec 2021 | TAX_WITHHOLDING | TREVENA INC | 93,561 | 0.65 USD | |
| 02 Dec 2021 | GRANT_AWARD | TREVENA INC | 1,250,000 | 0.00 USD | |
| 02 Aug 2021 | SALE | Nabriva Therapeutics AG | 777 | 1.20 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 17,500 | 0.00 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 28 Jun 2021 | PURCHASE | TREVENA INC | 56,200 | 1.79 USD | first after silence |
| 03 May 2021 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 92,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 28 Jun 2021.